Update on the management of pediatric acute promyelocytic leukemia

Clinical Advances in Hematology and Oncology

Volumn 4, Issue 4, 2006, Pages 263-265

  Ribeiro, Raul ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; ARSENIC TRIOXIDE; DEXAMETHASONE; FIBRINOGEN RECEPTOR AFFECTING AGENT; FRESH FROZEN PLASMA; GEMTUZUMAB OZOGAMICIN; MERCAPTOPURINE; METHOTREXATE; RETINOIC ACID;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BLURRED VISION; BODY WEIGHT DISORDER; BRAIN PSEUDOTUMOR; CANCER INCIDENCE; CHILDHOOD LEUKEMIA; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG FEVER; FATALITY; HEADACHE; HEART FAILURE; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HYPOTENSION; IMMUNOHISTOCHEMISTRY; INFECTION; KIDNEY FAILURE; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; PAPILLEDEMA; PERIPHERAL EDEMA; PLEURA EFFUSION; PROGNOSIS; PROMYELOCYTIC LEUKEMIA; RESPIRATORY DISTRESS; RETINOIC ACID SYNDROME; SURVIVAL RATE; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TREATMENT PLANNING; WEIGHT GAIN;

ADULT; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD COMPONENT TRANSFUSION; CHILD; CHILD, PRESCHOOL; FEMALE; HEMORRHAGE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; TRETINOIN;

EID: 33745218320     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. de Botton S, Coiteux V, Chevret U, et al. Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy. J Clin Oncol. 2004;22:1404-1412.
2. Falanga A, Rickles F. Pathogenesis and management of the bleeding diathesis in acute promyelocytic leukaemia. Best Pract Res Clin Haematol. 2003;16:463-482.
3. Feusner J, Gregory J Jr. Acute promyelocytic leukemia in children. Best Pract Res Clin Haematol. 2003;16:483-494.
4. Gale RE, Hills R, Pizzey AR, et al. Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia. Blood. 2005;106:3768-3776.
5. George B, Mathews V, Poonkuzhali B, et al. Hepatotoxicity profile of single agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia, its impact on clinical outcome and the effect of genetic polymorphisms on the incidence of hepatotoxicity. Leukemia. 2006 Mar 9; [Epub ahead of print].
6. Gomis F, Sanz J, Sempere A, et al. Immunofluorescent analysis with the anti-pml monoclonal antibody (PG-M3) for rapid and accurate genetic diagnosis of acute promyelocytic leukemia. Ann Hematol. 2004;83:687-690.
7. Lo Coco F, Ammatuna E, Noguera N. Treatment of acute promyelocytic leukemia with gemtuzumab ozogamicin. Clin Adv Hematol Oncol. 2006;4:57-62, 76-77.
8. Lo Coco F, Breccia M, Diverio D. Diagnostic value of detecting fusion proteins derived from chromosome translocations in acute leukaemia. Best Pract Res Clin Haematol. 2003;16:653-670.
9. Marty M, Ganem G, Fisher J, et al. Acute promyelocytic leukemia: restrospective study of 119 patients treated with daunorubicin. Nouv Rev Fr Hematol. 1984;26:371-378.
10. Ortega JJ, Madero L, Martin G, et al. Treatment with all-trans retinoic acid and anthracycline monochemotherapy for children with acute promyelocytic leukemia: a multicenter study by the PETHEMA Group. J Clin Oncol. 2005;23:7632-7640.
11. Sanz M, Tallman M, Lo-Coco F. Trick of the trade for the appropriate management of newly diagnosed acute promyelocytic leukemia. Blood. 2005;105:3019-3025.
12. Sanz M, Tallman M, Lo-Coco F. Practice points, consensus, and controversial issues in the management of patients with newly diagnosed acute promyelocytic leukemia. Oncologist. 2005;10:806-814.
13. Shen ZX, Shi ZZ, Fang J, et al. All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia. Proc Natl Acad Sci U S A. 2004;101:5328-5335.
14. Testi AM, Biondi A, Lo Coco F, et al. GIMEMA-AIEOPAIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children. Blood. 2005;106:447-453.